Saturday, 5 March 2016

Drug Delivery 2017

About Conference

Conference Series LLC proudly announces the commencement of its “11th World Drug Delivery Summit” which is going to be held during October 16-18, 2017 at New York, USA. The conference highlights the theme“Frontiers Innovations in Drug Delivery Technology”. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics Drug delivery, Novel Approaches on Product Development, Biopharmaceutics, vaccine drug delivery, Pharmaceutical Innovation in the 21st Century, New scientific approaches to international regulatory standards. The conference invites deligates from Leading Universities, Pharmaceutical companies, Formulation Scientists, Medical Devices, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects. Participating at Drug Delivery International conference will be an excellent opportunity to meet eminent personalities in the fields of pharmaceutics and learn about the latest technological advancements. 

Drug Delivery is one of the major contributors in global economic progress. The global pharmaceuticals market, in 2015, was $120 billion. The global pharmaceutical industry is currently worth over $145 billion, according to research conducted. The industry should exceed $167 billion in 2016. Realizing the importance, Conference Series LLC is organizing 11th World Drug Delivery conference in New York, USA this year paving way for sharing views and research, which will help the scientific world to adopt solutions for the problems of critical importance.
Drug Delivery 2017 is Anticipating 300+ Participation (70 Industry: 30 Academia) 5+ Keynote Speakers, 50+ Plenary Speakers, 20+ Exhibitors, 14 Innovative Educational Sessions, 5+ Workshops, B2B Meetings

Why Should I Attend?

Bridging the gap between Academia and Industry in novel research methods of DDS
Meeting with 70+ industrial experts, 30+ academic speakers, 50+Pharmaceutical Companies, 120+decision-makers interacting. Finding novel opportunities of doing NDDS business and dynamically providing the “value addition” to pharmaceutical R&D businesses. Novel approaches about the drug delivery systems development and industrializing insights & gain the latest technologies about novel drug delivery systems and applications
Emphasis on novel strategies for formulation and drug delivery system’s latest updates to drive your market share accordingly. Learn on the applications of novel DDS for treating major diseases to progress the drug portfolio industrialization pathways.

The U.S. constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6%. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. The global market for drug delivery systems in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. With large number of pharmaceutical, chemistry, biomedical departments and companies involved in drug delivery research U.S constitutes the highest number of researches going on. Approx. of 10 universities in Houston out of 500 universities in USA are into drug delivery research. There are approx. 230 major Drug delivery companies all over globe including that of 100 in USA and 10 in NewOrleans into drug delivery research apart from large number of pharmaceutical companies.

Conference Highlights

Special Issues

All accepted abstracts will be published in respective International Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref.

  See more at: